| Author |
Title |
JournalName |
Year D |
| Click on Column Headers to Re-Sort The Current List |
| Nash JF Jr, Meltzer HY, G... |
Elevation of serum prolactin and corticosterone concentrations in the ... |
J Pharmacol Exp Ther |
1988 |
| Price LH, Ricaurte GA, Kr... |
Neuroendocrine and mood responses to intravenous L-tryptophan in 3,4-m... |
Arch Gen Psychiatry |
1989 |
| Price LH, Ricaurte GA, Kr... |
Responses to I.V. L-tryptophan in MDMA Users |
NIDA Res Monogr |
1989 |
| Grob C, Bravo G, Walsh R |
Second thoughts on 3,4-methylenedioxymethamphetamine (MDMA) neurotoxic... |
Arch Gen Psychiatry |
1990 |
| Poland RE |
Diminished corticotropin and enhanced prolactin responses to 8-hydroxy... |
Neuropharmacology |
1990 |
| Ricaurte GA, Finnegan KT,... |
Aminergic metabolites in cerebrospinal fluid of humans previously expo... |
Ann N Y Acad Sci |
1990 |
| Gouzoulis E, von Bardeleb... |
Neuroendocrine and cardiovascular effects of MDE in healthy volunteers |
Neuropsychopharmacol... |
1993 |
| Strassman RJ, Qualls CR |
Dose-response study of N,N-dimethyltryptamine in humans. I. Neuroendoc... |
Arch Gen Psychiatry |
1994 |
| McCann UD, Ridenour A, Sh... |
Serotonin neurotoxicity after (+/-)3,4-methylenedioxymethamphetamine (... |
Neuropsychopharmacol... |
1994 |
| Grob CS, Poland RE, Chang... |
Psychobiologic effects of 3,4-methylenedioxymethamphetamine in humans:... |
Behav Brain Res |
1996 |
| Poland RE, Lutchmansingh ... |
Abnormal ACTH and prolactin responses to fenfluramine in rats exposed ... |
Psychopharmacology (... |
1997 |
| Gerra G, Zaimovic A, Giuc... |
Serotonergic function after (+/-)3,4-methylene-dioxymethamphetamine ('... |
Int Clin Psychopharm... |
1998 |
| Mas M, Farre M, de la Tor... |
Cardiovascular and neuroendocrine effects and pharmacokinetics of 3, 4... |
J Pharmacol Exp Ther |
1999 |
| McCann UD, Eligulashvili ... |
Altered neuroendocrine and behavioral responses to m-chlorophenylpiper... |
Psychopharmacology (... |
1999 |
| Gouzoulis-Mayfrank E, The... |
Psychopathological, neuroendocrine and autonomic effects of 3,4-methyl... |
Psychopharmacology (... |
1999 |
| Gerra G, Zaimovic A, Ferr... |
Long-lasting effects of (+/-)3,4-methylenedioxymethamphetamine (ecstas... |
Biol Psychiatry |
2000 |
| Rothman RB, Baumann MH, D... |
Amphetamine-type central nervous system stimulants release norepinephr... |
Synapse |
2001 |
| Verkes RJ, Gijsman HJ, Pi... |
Cognitive performance and serotonergic function in users of ecstasy |
Psychopharmacology (... |
2001 |
| Hatzidimitriou G, Tsai EH... |
Altered prolactin response to M-chlorophenylpiperazine in monkeys prev... |
Synapse |
2002 |
| Gouzoulis-Mayfrank E, Bec... |
Neuroendocrine abnormalities in recreational ecstasy (MDMA) users: is ... |
Biol Psychiatry |
2002 |
| Harris DS, Baggott M, Men... |
Subjective and hormonal effects of 3,4-methylenedioxymethamphetamine (... |
Psychopharmacology (... |
2002 |
| Gerra G, Zaimovic A, Moi ... |
Effects of (+/-) 3,4-methylene-dioxymethamphetamine (ecstasy) on dopam... |
Behav Brain Res |
2002 |
| Pacifici R, Pichini S, Zu... |
Paroxetine Inhibits Acute Effects of MDMA on the Immune System in Huma... |
J Pharmacol Exp Ther |
2004 |
| Farre M, De La Torre R, O... |
Repeated doses administration of MDMA in humans: pharmacological effec... |
Psychopharmacology (... |
2004 |
| Murnane KS, Fantegrossi W... |
Endocrine and neurochemical effects of 3,4-methylenedioxymethamphetami... |
J Pharmacol Exp Ther |
2010 |
